On Monday, Arcus Biosciences (RCUS) cleared an important performance benchmark, with its Relative Strength (RS) Rating jumping into the 80-plus percentile with an improvement to 85, up from 80 the day before. Looking For The Best Stocks To Buy And Watch? Start Here This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best)…